糖尿病对心力衰竭患者长期生存结局的预后影响:一项荟萃分析
该荟萃分析纳入31项注册研究和12项临床试验,共381,725例急慢性心力衰竭患者,中位随访3年。糖尿病与全因死亡、心血管死亡、住院及全因死亡或住院复合终点风险升高相关,且在慢性心衰患者中影响大于急性心衰患者。
要点
- 糖尿病与心衰患者全因死亡风险升高相关(随机效应HR 1.28,95%CI 1.21-1.35)。
- 糖尿病与心血管死亡(HR 1.34)、住院(HR 1.35)及复合终点(HR 1.41)风险升高相关。
- 糖尿病对死亡和住院的影响在慢性心衰患者中大于急性心衰患者。
核心结论
- 该更新荟萃分析显示,糖尿病本身对急性和慢性心衰患者的长期生存和住院风险产生不良影响。
研究设计与样本
- 检索PubMed、Scopus和Web of Science从1990年1月至2016年10月的数据,纳入样本量≥1,000例、随访至少1年的观察性注册研究和随机对照试验,采用随机效应模型进行荟萃分析。
- 最终分析共纳入31项注册研究和12项临床试验,381,725例急性和慢性心衰患者,中位随访3年,记录102,036例全因死亡。
主要发现
- 糖尿病与全因死亡风险升高相关(随机效应HR 1.28,95%CI 1.21-1.35)。
- 糖尿病与心血管死亡风险升高相关(HR 1.34,95%CI 1.20-1.49)。
- 糖尿病与住院风险升高相关(HR 1.35,95%CI 1.20-1.50)。
- 糖尿病与全因死亡或住院复合终点风险升高相关(HR 1.41,95%CI 1.29-1.53)。
- 糖尿病对死亡和住院的影响在慢性心衰患者中大于急性心衰患者。
临床怎么用
- 原文未据此给出推荐。
局限性
- 局限性包括高异质性和各研究间混杂因素调整程度不一。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Several studies have explored the impact of diabetes on mortality in patients with heart failure (HF). However, the extent to which diabetes may confer risk of mortality and hospitalization in this patient population remains imperfectly known. Here we examine the independent prognostic impact of diabetes on the long-term risk of mortality and hospitalization in patients with HF. RESEARCH DESIGN AND METHODS: PubMed, Scopus, and Web of Science from January 1990 to October 2016 were the data sources used. We included large (n ≥1,000) observational registries and randomized controlled trials with a follow-up duration of at least 1 year. Eligible studies were selected according to predefined keywords and clinical outcomes. Data from selected studies were extracted, and meta-analysis was performed using random-effects modeling. RESULTS: A total of 31 registries and 12 clinical trials with 381,725 patients with acute and chronic HF and 102,036 all-cause deaths over a median follow-up of 3 years were included in the final analysis. Diabetes was associated with a higher risk of all-cause death (random-effects hazard ratio [HR] 1.28 [95% CI 1.21, 1.35]), cardiovascular death (1.34 [1.20, 1.49]), hospitalization (1.35 [1.20, 1.50]), and the combined end point of all-cause death or hospitalization (1.41 [1.29, 1.53]). The impact of diabetes on mortality and hospitalization was greater in patients with chronic HF than in those with acute HF. Limitations included high heterogeneity and varying degrees of confounder adjustment across individual studies. CONCLUSIONS: This updated meta-analysis shows that the presence of diabetes per se adversely affects long-term survival and risk of hospitalization in patients with acute and chronic HF.
引用
- Dauriz M, Mantovani A, Bonapace S, et al. Prognostic Impact of Diabetes on Long-term Survival Outcomes in Patients With Heart Failure: A Meta-analysis. Diabetes Care. 2017. PMID: 29061587. doi:10.2337/dc17-0697
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。